Você procurou por: sulfonylurea (Dinamarquês - Inglês)

sulfonylurea
sulphonylurea

med sulfonylurea
with sulpho- nylurea

sulfonylurea-herbicider
sulfonylurea herbicides

metformin og sulfonylurea
metformin and sulphonylurea

med metformin og sulfonylurea
with metformin and sulpho- nylurea

pioglitazon i kombinationsbehandling med sulfonylurea
pioglitazone in combination therapy with sulphonylurea

ukrudtbekæmpelsesmidler, på basis af sulfonylurea
herbicides based on urea; uracil and sulphonylurea, put up in forms or packings for retail sale or as preparations or articles

medicin, kaldet sulfonylurea, eller
called a sulphonylurea, or 25

sulfonylurea- derivater som glimepirid passerer over i brystmælken.
20 sulphonylurea-derivatives like glimepiride pass into the breast milk.

selvmonitorering af blodglucose kan være nødvendigt for at justere dosis af sulfonylurea.
blood glucose self-monitoring may be necessary to adjust the dose of sulphonylurea.

- et sulfonylurea hos patienter med utilstrækkelig glykæmisk kontrol på trods af maksimal
- a sulphonylurea, in patients with insufficient glycaemic control despite maximal tolerated dose

samtidig administration af pioglitazon og sulfonylurinstoffer synes ikke at påvirke farmakokinetikken af sulfonylurea.
co-administration of pioglitazone with sulphonylureas does not appear to affect the pharmacokinetics of the sulphonylurea.

tolereret dosis sulfonylurea og til hvem metformin ikke er egnet på grund af kontraindikationer eller intolerance
of a sulphonylurea and for whom metformin is inappropriate due to contraindications or intolerance,

hyppigheden af ødemer for sammenligningsgrupperne (sulfonylurea, metformin) var 2 ­ 5%.
the oedema rates for comparator groups (sulphonylurea, metformin) were 2 ­ 5%.

i forbindelse med anvendelsen af sulfonylurea bør nedsættelse af sulfonylureadosis overvejes for at reducere risikoen for hypoglykæmi.
to reduce the risk of hypoglycaemia associated with the use of a sulphonylurea, reduction in the dose of sulphonylurea should be considered.

når galvus kombineres med et sulfonylurea, er den anbefalede dosis af vildagliptin 50 mg én gang daglig om morgenen.
when used in dual combination with a sulphonylurea, the recommended dose of vildagliptin is 50 mg once daily administered in the morning.

nogle patienter har oplevet følgende bivirkninger, mens de tog jalra og et sulfonylurea:  almindelige:
some patients have had the following side effects while taking jalra and a sulphonylurea:  common:

nogle patienter har oplevet følgende bivirkninger, mens de tog galvus og et sulfonylurea: • almindelige:
some patients have had the following side effects while taking galvus and a sulphonylurea: • common:

humalog kan anvendes sammen med en længerevirkende insulin eller orale diabetes- lægemidler (sulfonylurea).
humalog can be used with a longer-acting insulin or oral diabetic medicines (sulphonylureas).

behandling af patienter, der lider af g6pd- mangel, med lægemidler der indeholder sulfonylurea, kan medføre hæmolytisk anæmi.
treatment of patients with g6pd-deficiency with sulfonylurea agents can lead to haemolytic anaemia.